G.V.Pharma, a.s.
ActiveKey figures
Key figures
2025Dividends
calculatedNo dividends were distributed.
Equity decreased by 53 399 € other than from retained earnings — e.g. a share capital reduction, a payout from other funds or a revaluation. The open data does not show whether this was a payout to shareholders.
Summary: G.V.Pharma, a.s.
What kind of company is it?
G.V.Pharma, a.s. (IČO 31709249) is a joint-stock company (a.s.). The company was incorporated in 1995 and has existed for 31 years. Registered office according to the register: Hlohovec. Main activity according to the Statistical Office: výroba farmaceutických prípravkov (SK NACE 2120). Size category by number of employees: 25–49 employees.
Who runs the company and who owns it?
The statutory body has 3 members. The supervisory board has 3 members. The registered capital is 33 200 €.
How is the company doing financially?
Revenue for 2025 was 2 479 023 €, down 10,6 % on the previous year (2 772 842 €). From 2021 to 2025, revenue grew by an average of 16,4 % per year. 2025 ended with a loss of 54 121 €. The company was profitable in 1 of the 5 reported years. Personnel costs for 2025 were 794 029 €. At the end of 2025 the company had total assets of 4 902 638 € and equity of 4 486 491 € (equity ratio 91,5 %).
Where does the data come from and how current is it?
Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 11. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.
Summary of annual reports2021–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue (net turnover) | 1 350 776 | 1 337 848 | 3 288 445 | 2 772 842 | 2 479 023 |
| Profit for the reporting year | -94 860 | -699 028 | 451 029 | -49 028 | -54 121 |
| Retained earnings of previous periods | 5 367 606 | 5 272 745 | 4 630 511 | 4 742 540 | 4 693 511 |
| Total assets | 5 838 198 | 4 701 938 | 5 372 722 | 5 180 119 | 4 902 638 |
| Total liabilities | 397 952 | 142 281 | 318 058 | 586 107 | 416 147 |
| Total equity | 5 440 246 | 4 559 657 | 5 054 664 | 4 594 012 | 4 486 491 |
| Calculated dividends | — | 0 | 0 | 339 000 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Documents in the Register of Financial Statements10
- 2025 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2025 Úč POD · 12 pp.
- 2025 Úč POD
- 2024 Úč POD · 12 pp.
- 2024 Úč POD
- 2023 Úč POD · 12 pp.
- 2023 Úč POD
- 2022 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2022 Úč POD · 12 pp.
- 2022 Úč POD
Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).
Similar companies
- Pharmagal, spol. s.r.o. · Nitra
- hameln rds s. r. o. · Modra
- BEL - MIDITECH, s.r.o. · Kráľová pri Senci
- MED-PLANT, s.r.o. · Modra
- VALOVIČ, s.r.o. · Bratislava
- GALVEX, spol. s r.o. · Banská Bystrica
- PANACEA, s.r.o. · Žilina
- IMUNA PHARM, a.s. · Šarišské Michaľany
- PHARMAGAL - BIO, spol. s r.o. · Nitra
- BIOM-R, s. r. o. · Bratislava